New Key Statistics Module, Z-Score and F-Score
SZSE:301211 Key Ratios
Market Cap ¥ M | 5,232.96 |
Enterprise Value ¥ M | 3,732.95 |
P/E(ttm) | 49.11 |
PE Ratio without NRI | 56.25 |
Forward PE Ratio | -- |
Price/Book | 2.28 |
Price/Sales | 11.45 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 441.97 |
Payout Ratio % | 1.49 |
Revenue (TTM) ¥ M | 454.00 |
EPS (TTM) ¥ | 0.37 |
Beneish M-Score | -2.74 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -2.90 |
y-y EBITDA Growth Rate % | -59.10 |
EV-to-EBIT | 32.49 |
EV-to-EBITDA | 32.49 |
PEG | -- |
Shares Outstanding M | 288.00 |
Net Margin (%) | 23.38 |
Operating Margin % | 9.85 |
Pre-tax Margin (%) | 25.21 |
Quick Ratio | 13.41 |
Current Ratio | 14.62 |
ROA % (ttm) | 4.27 |
ROE % (ttm) | 4.56 |
ROIC % (ttm) | 6.59 |
Dividend Yield % | 2.59 |
Altman Z-Score | 23.48 |
SZSE:301211 Number of Guru Trades
SZSE:301211 Volume of Guru Trades
Gurus Latest Trades with SZSE:301211
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301211 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hubei Biocause Heilen Pharmaceutical Co Ltd Insider Transactions
No Available Data